Adaptive radiotherapy and AI in head and neck cancer

Over 12,000 patients are diagnosed with head and neck cancer across the UK every year. Alcohol and tobacco use have long been established as primary risk factors for the development of these cancers. However, there has been a notable increase in the cases of oropharyngeal cancer in recent years, particularly those linked to the oncogenic human papillomavirus (HPV), in regions of North America and Europe that is also replicated in the UK.

To access the full article as a pdf please sign up to our newsletter.

The content on this page is provided by the individuals concerned and does not represent the views or opinions of RAD Magazine.